FamiCord AG (VTIAF)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Jakub Julian Baran | Chairman of the Management Board & CEO | -- | -- | -- |
| Mr. Tomasz Franciszek Baran | Vice President of the Management Board & Chief Commercial Officer | -- | -- | -- |
| Thomas Pfaadt | Chief Financial Officer | -- | -- | -- |
| Santiago Luengo | Managing Director of Secuvita | -- | -- | -- |
FamiCord AG
- Sector:
- Healthcare
- Industry: Medical Care Facilities
- Full Time Employees:
- 783
Description
FamiCord AG engages in the collection, processing, cryopreservation, and storage of stem cells from umbilical cord blood and tissue and postnatal tissue in Germany, Poland, Portugal, and internationally. It operates through Subgroup Vita 34 And Subgroup PBKM segments. The company produces and develops advanced therapies, genetic tests, and analyses for third parties. It also develops products and drugs based on cells, tissues, and blood for medical applications; and produces and manufactures viral vectors and CAR-T cells. In addition, the company provides biobanking services, such as freezing sperm and storage of adipose tissue and the isolation of cells from the stored materials. The company was formerly known as VITA 34 AG and changed its name to FamiCord AG in February 2025. FamiCord AG was founded in 1997 and is based in Leipzig, Germany.
Corporate Governance
Upcoming Events
April 30, 2025 at 10:59 AM UTC
FamiCord AG Earnings Date
Recent Events
Recent Events Information Not Available